Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Cutera | CUTR | 31. oct 2024 | 0.58 | -9.52 |
CVB Financial | CVBF | 31. oct 2024 | 19.43 | -1.57 |
CVD Equipment | CVV | 31. oct 2024 | 2.92 | -1.35 |
CVR Energy | CVI | 31. oct 2024 | 15.90 | -7.07 |
Cvr Partners LP Unit | UAN | 31. oct 2024 | 66.18 | +1.72 |
CVRx | CVRX | 31. oct 2024 | 13.12 | -6.75 |
CVS Health | CVS | 31. oct 2024 | 56.46 | +0.12 |
CXApp A | CXAI | 31. oct 2024 | 1.41 | -2.76 |
CyberArk Software | CYBR | 31. oct 2024 | 276.52 | -2.27 |
Cybin | CYBN | 31. oct 2024 | 10.03 | +1.21 |
Cyclacel Pharmaceuticals | CYCC | 31. oct 2024 | 0.65 | -1.22 |
Cyclacel Pharmaceuticals Pref | CYCCP | 31. oct 2024 | 7.30 | +1.81 |
Cyclerion Therapeutics | CYCN | 31. oct 2024 | 2.89 | -3.67 |
Cyclo Therapeutics | CYTH | 31. oct 2024 | 0.75 | +3.74 |
Cyngn | CYN | 31. oct 2024 | 3.50 | -10.71 |
Cytek Biosciences | CTKB | 31. oct 2024 | 4.95 | +0.92 |
Cytokinetics | CYTK | 31. oct 2024 | 51.00 | -0.60 |
Cytomed Therapeutics | GDTC | 31. oct 2024 | 2.41 | +8.29 |
CytomX Therapeutics | CTMX | 31. oct 2024 | 1.00 | +0.37 |
Cytosorbents | CTSO | 31. oct 2024 | 1.01 | 0.00 |
D-MARKET Electronic Services & Trading ADR | HEPS | 31. oct 2024 | 3.19 | -5.34 |
D-Wave Quantum | QBTS | 31. oct 2024 | 1.06 | -6.19 |
D.R. Horton | DHI | 31. oct 2024 | 169.00 | -0.17 |
Dada Nexus ADR | DADA | 31. oct 2024 | 1.67 | -4.57 |
Daily Journal | DJCO | 31. oct 2024 | 485.00 | -2.63 |
Dakota Gold | DC | 31. oct 2024 | 2.19 | -6.41 |
Daktronics | DAKT | 31. oct 2024 | 13.03 | -1.88 |
DallasNews A | DALN | 31. oct 2024 | 5.43 | -3.38 |
Dana | DAN | 31. oct 2024 | 7.67 | -8.58 |
Danaher | DHR | 31. oct 2024 | 245.66 | +1.38 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.